Quellen: Die Informationen in diesem Artikel sind durch aktuelle medizinische Literatur und Leitlinien belegt, sowie gynäkologische Fachportale und Studien zu PCOS und hypothalamischer Amenorrhö (siehe unten). Sie wurden im Einklang mit geltenden EU Health Claims formuliert. Trotzdem ersetzt dieser Überblick keine individuelle ärztliche Beratung.
Bozdag, G., Mumusoglu, S., Zengin, D., Karabulut, E., & Yildiz, B. O. (2016). The prevalence and phenotypic features of polycystic ovary syndrome: A systematic review and meta-analysis.Human Reproduction, 31(12), 2841–2855.https://doi.org/10.1093/humrep/dew218
Cleveland Clinic. (2023, March 23). Amenorrhea: Types, causes, symptoms, diagnosis & treatment. Cleveland Clinic.https://my.clevelandclinic.org/health/diseases/3924-amenorrhea
Eunice Kennedy Shriver National Institute of Child Health and Human Development. (2017, January 31). Amenorrhea.https://www.nichd.nih.gov/health/topics/amenorrhea
European Food Safety Authority Panel on Dietetic Products, Nutrition and Allergies. (2009). Scientific Opinion on the substantiation of health claims related to inositol and cognitive function (ID 1588) pursuant to Article 13(1) of Regulation (EC) No 1924/2006.EFSA Journal, 7(9), 1304.https://doi.org/10.2903/j.efsa.2009.1304
Fitz, V., Graca, S., Mahalingaiah, S., Liu, J., Lai, L., Butt, A., Armour, M., Rao, V., Naidoo, D., Maunder, A., Yang, G., Vaddiparthi, V., Witchel, S. F., Pena, A., Spritzer, P. M., Li, R., Tay, C., Mousa, A., Teede, H., & Ee, C. (2024). Inositol for polycystic ovary syndrome: A systematic review and meta-analysis to inform the 2023 update of the international evidence-based PCOS guidelines.Journal of Clinical Endocrinology & Metabolism, 109(6), 1630–1655.https://doi.org/10.1210/clinem/dgad762
Gordon, C. M., Ackerman, K. E., Berga, S. L., Kaplan, J. R., Mastorakos, G., Misra, M., Murad, M. H., Santoro, N. F., & Warren, M. P. (2017). Functional hypothalamic amenorrhea: An Endocrine Society clinical practice guideline.Journal of Clinical Endocrinology & Metabolism, 102(5), 1413–1439.https://doi.org/10.1210/jc.2017-00131
Mayo Clinic. (2023, February 9). Amenorrhea – Symptoms and causes.https://www.mayoclinic.org/diseases-conditions/amenorrhea/symptoms-causes/syc-20369299
Melmed, S., Casanueva, F. F., Hoffman, A. R., Kleinberg, D. L., Montori, V. M., Schlechte, J. A., & Wass, J. A. H. (2011). Diagnosis and treatment of hyperprolactinemia: An Endocrine Society clinical practice guideline.Journal of Clinical Endocrinology & Metabolism, 96(2), 273–288.https://doi.org/10.1210/jc.2010-1692
Office on Women’s Health. (2024, December 6). Thyroid disease. U.S. Department of Health & Human Services.https://www.womenshealth.gov/a-z-topics/thyroid-disease
Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L. J., Piltonen, T., & Norman, R. J. (2018). Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.Fertility and Sterility, 110(3), 364–379.https://doi.org/10.1016/j.fertnstert.2018.05.004
Unfer, V., Facchinetti, F., Orrù, B., Giordani, B., & Nestler, J. E. (2017). Myo-inositol effects in women with PCOS: A meta-analysis of randomized controlled trials.Endocrine Connections, 6(8), 647–658.https://doi.org/10.1530/EC-17-0243